These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10025963)

  • 1. Possible role for ligand binding of histidine 81 in the second transmembrane domain of the rat prostaglandin F2alpha receptor.
    Rehwald M; Neuschäfer-Rube F; de Vries C; Püschel GP
    FEBS Lett; 1999 Jan; 443(3):357-62. PubMed ID: 10025963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor.
    Neuschäfer-Rube F; Engemaier E; Koch S; Böer U; Püschel GP
    Biochem J; 2003 Apr; 371(Pt 2):443-9. PubMed ID: 12519077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of domains conferring ligand binding specificity to the prostanoid receptor. Studies on chimeric prostacyclin/prostaglandin D receptors.
    Kobayashi T; Kiriyama M; Hirata T; Hirata M; Ushikubi F; Narumiya S
    J Biol Chem; 1997 Jun; 272(24):15154-60. PubMed ID: 9182536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling.
    Stitham J; Stojanovic A; Merenick BL; O'Hara KA; Hwa J
    J Biol Chem; 2003 Feb; 278(6):4250-7. PubMed ID: 12446735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of prostaglandin F2alpha receptors in bovine corpus luteum cell membranes.
    Rao CV
    Mol Cell Endocrinol; 1976 Nov; 6(1):1-16. PubMed ID: 12062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human DP and EP2 prostanoid receptors take on distinct forms depending on the diverse binding of different ligands.
    Suganami A; Fujino H; Okura I; Yanagisawa N; Sugiyama H; Regan JW; Tamura Y; Murayama T
    FEBS J; 2016 Nov; 283(21):3931-3940. PubMed ID: 27636113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs.
    Kedzie KM; Donello JE; Krauss HA; Regan JW; Gil DW
    Mol Pharmacol; 1998 Sep; 54(3):584-90. PubMed ID: 9730918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors. Analysis of chimeric rat/human TP receptors.
    Dorn GW; Davis MG; D'Angelo DD
    J Biol Chem; 1997 May; 272(19):12399-405. PubMed ID: 9139686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor.
    Angelova K; Narayan P; Simon JP; Puett D
    Mol Endocrinol; 2000 Apr; 14(4):459-71. PubMed ID: 10770485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of ligand binding domains of the prostanoid receptors].
    Kobayashi T; Ushikubi F; Narumiya S
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():127P-129P. PubMed ID: 10629869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Breyer RM
    J Biol Chem; 2005 Sep; 280(37):32442-51. PubMed ID: 16030019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of aspartate-133 and histidine-458 in the mechanism of tryptophan indole-lyase from Proteus vulgaris.
    Demidkina TV; Zakomirdina LN; Kulikova VV; Dementieva IS; Faleev NG; Ronda L; Mozzarelli A; Gollnick PD; Phillips RS
    Biochemistry; 2003 Sep; 42(38):11161-9. PubMed ID: 14503866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational, kinetic, and NMR studies of the mechanism of E. coli GDP-mannose mannosyl hydrolase, an unusual Nudix enzyme.
    Legler PM; Massiah MA; Mildvan AS
    Biochemistry; 2002 Sep; 41(35):10834-48. PubMed ID: 12196023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid residues conferring ligand binding properties of prostaglandin I and prostaglandin D receptors. Identification by site-directed mutagenesis.
    Kobayashi T; Ushikubi F; Narumiya S
    J Biol Chem; 2000 Aug; 275(32):24294-303. PubMed ID: 10827082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-induced phosphorylation by G protein-coupled receptor kinases of the EP4 receptor carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor hybrid.
    Neuschäfer-Rube F; Oppermann M; Möller U; Böer U; Püschel GP
    Mol Pharmacol; 1999 Aug; 56(2):419-28. PubMed ID: 10419563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
    Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
    Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of agonist function at fusion proteins between the IP prostanoid receptor and cognate, unnatural and chimaeric G-proteins.
    Fong CW; Milligan G
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):457-63. PubMed ID: 10455034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter.
    Schuster VL; Itoh S; Andrews SW; Burk RM; Chen J; Kedzie KM; Gil DW; Woodward DF
    Mol Pharmacol; 2000 Dec; 58(6):1511-6. PubMed ID: 11093791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
    Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
    Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.